Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Open or close the search fields display
80 Studies found for: daratumumab multiple myeloma AND Refractory Multiple Myeloma AND response rate

Terms and Synonyms Searched:

Terms Search Results* Entire Database**
Synonyms
daratumumab multiple myeloma -- 0 studies
multiple myeloma 80 studies 3,015 studies
myeloma 80 studies 3,006 studies
Kahler disease -- 4 studies
Myelomatosis -- 6 studies
Plasma cell dyscrasia -- 31 studies
plasma cell neoplasm -- 337 studies
myeloma 80 studies 3,010 studies
Kahler disease -- 4 studies
Myelomatosis -- 6 studies
plasma cell neoplasm -- 337 studies
multiple 80 studies 72,775 studies
Multi 7 studies 23,601 studies
Several 1 studies 14,871 studies
Many 1 studies 15,905 studies
Numerous -- 1,750 studies
Plural -- 10 studies
daratumumab 80 studies 209 studies
Darzalex 20 studies 77 studies
anti-CD38 monoclonal antibody 16 studies 49 studies
humax-CD 38 3 studies 28 studies
Refractory Multiple Myeloma 72 studies 1,076 studies
Refractory Plasma Cell Myeloma 4 studies 93 studies
Plasma cell myeloma refractory -- 1 studies
Refractory 80 studies 11,175 studies
Intractable -- 416 studies
Unresponsive -- 367 studies
response rate 80 studies 20,435 studies
Frequency of Responses -- 32 studies
frequency response -- 31 studies
rate responses -- 158 studies
Response Frequency -- 9 studies
rate 80 studies 121,783 studies
Rating 6 studies 24,038 studies
Rated 3 studies 10,954 studies
response 80 studies 90,102 studies
Answer 3 studies 8,403 studies

   
-- No studies found
* Number of studies in the search results containing the term or synonym
** Number of studies in the entire database containing the term or synonym

Related Terms: